Title:
COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF AS DRUG INTERMEDIATE
Document Type and Number:
WIPO Patent Application WO/2020/151620
Kind Code:
A1
Abstract:
Disclosed are a compound as represented by formula II, and an isomer or available salt thereof. Also disclosed specifically are a manufacturing method for the compound, and the isomer or available salt thereof, and an application of the compound, and the isomer or available salt thereof as a drug intermediate. The compound, and the isomer or available salt thereof can be used as an intermediate for preparing a drug for preventing or treating diabetes, or as an intermediate for preparing a drug for inhibiting rise of the blood sugar and lowering the blood sugar level.
More Like This:
| WO/2019/032936 | LINCONSAMIDE ANTIBIOTICS AND USES THEREOF |
| JP2011506527 | ε-Caprolactam manufacturing method |
| WO/2013/152848 | GLYCOMIMETICS AS PSEUDOMONAS AERUGINOSA LECTIN INHIBITORS |
Inventors:
ZHANG BAOXIAN (CN)
ZHANG HONGWU (CN)
HU JIE (CN)
KANG ZHIYUN (CN)
XUE CHUNMEI (CN)
LI WENHUI (CN)
SONG YANWEI (CN)
ZHANG HONGWU (CN)
HU JIE (CN)
KANG ZHIYUN (CN)
XUE CHUNMEI (CN)
LI WENHUI (CN)
SONG YANWEI (CN)
Application Number:
PCT/CN2020/073013
Publication Date:
July 30, 2020
Filing Date:
January 19, 2020
Export Citation:
Assignee:
BEIJING INCREASE INNOVATIVE DRUG CO LTD (CN)
International Classes:
C07D309/02; A61K31/351; A61P3/10
Foreign References:
| CN101103013A | 2008-01-09 | |||
| JP2008031161A | 2008-02-14 | |||
| CN1989132A | 2007-06-27 | |||
| CN102656165A | 2012-09-05 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: